Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier

Original Research

(2459) Views  (672) Full article downloads

Authors: Yasutaka Mori, Shingo Nakamura, Satoko Kishimoto, et al

Published Date March 2010 Volume 2010:5 Pages 147 - 155

DOI: http://dx.doi.org/10.2147/IJN.S8692

Yasutaka Mori^1,3,4, Shingo Nakamura², Satoko Kishimoto¹, Mitsuyuki Kawakami⁴, Satoshi Suzuki⁴, Takemi Matsui⁴, Masayuki Ishihara¹

¹Research Institute, ²Department of Surgery, National Defense Medical College, Tokorozawa, Saitama, Japan; ³Aeromedical Laboratory, Japan Air Self-Defense Force, Sayama, Saitama, Japan; ⁴Faculty of System Design, Tokyo Metropolitan University, Hino, Tokyo, Japan

Abstract: We produced low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as a carrier for heparin-binding growth factors, such as fibroblast growth factor-2 (FGF-2). A mixture of low-molecular-weight heparin (MW: about 5000 Da, 6.4 mg/mL) and protamine (MW: about 3000 Da, 10 mg/mL) at a ratio of 7:3 (vol:vol) yields a dispersion of microparticles (1–6 μm in diameter). In this study, diluted low-molecular-weight heparin solution in saline (0.32 mg/mL) mixed with diluted protamine (0.5 mg/mL) at a ratio at 7:3 (vol:vol) resulted in soluble nanoparticles (112.5 ± 46.1 nm in diameter). The generated NPs could be then stabilized by adding 2 mg/mL dextran (MW: 178-217 kDa) and remained soluble after lyophilization of dialyzed LMW-H/P NP solution. We then evaluated the capacity of LMW-H/P NPs to protect activity of FGF-2. Interaction between FGF-2 and LMW-H/P NPs substantially prolonged the biological half-life of FGF-2. Furthermore, FGF-2 molecules were protected from inactivation by heat and proteolysis in the presence of LMW-H/P NPs.

Keywords: polyelectrolyte complexes, nanoparticles, fibroblast growth factor-2, drug carrier